Anti-adhesive Effect and Safety of “Collabarrier®” by using double blind test in Thyroid Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005745

Enrollment

100

Registered

2021-01-08

Start date

2017-11-28

Completion date

Unknown

Last updated

2021-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients were randomized during the final steps of thyroidectomy, with the patient unaware of the assigned group. A total of 100 patients were randomized 1:1 to thyroidectomy with and without C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients aged 20 to 65 years old 2) Patients who consented to the study and obtained consent for the study 3) Patients planning to undergo thyroidectomy with an incision due to thyroid disease 4) Patients with no significant abnormal findings in laboratory and voice tests before surgery

Exclusion criteria

Exclusion criteria: 1) Patients judged to be inappropriate by the person in charge of the clinical trial 2) Take aspirin and antiplatelet drugs within 7 days of hospitalization 3) History of esophageal and airway related diseases 4) History of keloid or hypertrophic scar 5) Patients who participated in other clinical trials within 30 days 6) Patients scheduled to undergo lateral cervical lymph node resection 7) Patients who are clinically judged to have already formed adhesions after receiving frontal irradiation and surgery in the past 8) Patients with a history of allergies to drugs (especially Poloxamer, gelatin, chitosan, etc.)

Design outcomes

Primary

Measure	Time frame
effectiveness in anti-adhesion	—

Secondary

Measure	Time frame
safety	—

Countries

Korea, Republic of

Contacts

Public ContactHyeong Won Yu

Seoul National University Bundang Hospital

Outcome results